We are live on ! Find out more
AIM

Alambic Investment Management Portfolio holdings

AUM $9.12M
1-Year Est. Return 34.54%
This Fund
S&P 500
This Quarter Est. Return
+10.58%
1 Year Est. Return
+34.54%
3 Year Est. Return
+47.56%
5 Year Est. Return
+107.87%
10 Year Est. Return
AUM
$9.12M
AUM Growth
-$30.8M
Cap. Flow
-$30.4M
Cap. Flow %
-333.8%
Top 10 Hldgs %
37.71%
Holding
181
New
18
Increased
8
Reduced
44
Closed
108

Sector Composition

1 Technology 35.8%
2 Healthcare 31.98%
3 Industrials 8.99%
4 Energy 5.56%
5 Consumer Staples 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYCN icon
51
Cyclerion Therapeutics
CYCN
$15.6M
$63K 0.69%
515
-538
-51% -$61.5K
GRTS
52
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$57K 0.63%
+21,655
New +$80.4K
ARAY icon
53
Accuray
ARAY
$30.9M
$54K 0.59%
22,354
-7,300
-25% -$17K
ARC
54
DELISTED
ARC Document Solutions, Inc.
ARC
$54K 0.59%
60,143
-31,858
-35% -$33.7K
SYBX
55
DELISTED
Synlogic
SYBX
$52K 0.57%
1,727
-1,013
-37% -$33.3K
FLNT
56
Fluent
FLNT
$109M
$45K 0.49%
3,030
-1,467
-33% -$21.3K
ATRS
57
DELISTED
Antares Pharma, Inc.
ATRS
$45K 0.49%
16,769
-28,800
-63% -$79.7K
EMKR
58
DELISTED
Emcore Corp
EMKR
$44K 0.48%
1,339
-20
-1% -$661
NAGE
59
Niagen Bioscience
NAGE
$271M
$43K 0.47%
+10,810
New +$52.1K
CBIO
60
Crescent Biopharma
CBIO
$410M
$42K 0.46%
+138
New +$52.7K
ETTX
61
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$42K 0.46%
+20,682
New +$59K
COTY icon
62
Coty
COTY
$2.28B
$41K 0.45%
+15,200
New +$57.4K
SVRA icon
63
Savara
SVRA
$1.13B
$40K 0.44%
+36,546
New +$62.5K
LITS
64
Lite Strategy Inc
LITS
$32.8M
$39K 0.43%
+625
New +$37.7K
RLH
65
DELISTED
Red Lions Hotel Corporation
RLH
$38K 0.42%
17,688
DRRX
66
DELISTED
DURECT Corp
DRRX
$36K 0.39%
2,088
+18
+0.9% +$361
ALSK
67
DELISTED
Alaska Communications Systems
ALSK
$32K 0.35%
15,800
+1,000
+7% +$2.31K
HLX icon
68
Helix Energy Solutions
HLX
$1.4B
$31K 0.34%
+12,712
New +$46.4K
VYNE icon
69
VYNE Therapeutics
VYNE
$24.9M
$25K 0.27%
+211
New +$24.6K
SYNC
70
DELISTED
Synacor, Inc.
SYNC
$25K 0.27%
16,700
-3,700
-18% -$4.5K
ABEO icon
71
Abeona Therapeutics
ABEO
$402M
$24K 0.26%
+924
New +$58.3K
PVLA
72
Palvella Therapeutics
PVLA
$2.18B
$23K 0.25%
+136
New +$31K
FET icon
73
Forum Energy Technologies
FET
$591M
$10K 0.11%
936
-735
-44% -$7.39K
AA icon
74
Alcoa
AA
$12B
-20,800
Closed -$234K
ADSK icon
75
Autodesk
ADSK
$46.1B
-1,079
Closed -$258K

Similar funds

Alambic Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Alambic Investment Management held 181 positions worth $9.12M, down 77% from $39.9M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Alambic Investment Management withdrew a net $30.4M in Q3 2020, closing 108 positions and reducing 44 holdings. Its most notable exit was Collectors Universe, an estimated $605K position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alambic Investment Management opened a new position in Satsuma Pharmaceuticals, Inc. Common Stock worth $81K.

  • Alambic Investment Management's largest Q3 2020 buy was Satsuma Pharmaceuticals, Inc. Common Stock: 20,711 shares worth $81K.
  • Alambic Investment Management added most to Rimini Street in Q3 2020, an estimated $55.9K increase.
  • Alambic Investment Management's biggest Q3 2020 reduction was NEOPHOTONICS CORP, cutting an estimated $556K.
  • Alambic Investment Management fully exited Collectors Universe in Q3 2020, selling an estimated $605K.
  • Alambic Investment Management's ten largest holdings make up 38% of its $9.12M portfolio in Q3 2020.
  • Alambic Investment Management opened 18 new positions and closed 108 in Q3 2020.
  • Alambic Investment Management's portfolio value fell 77% quarter-over-quarter to $9.12M.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.